| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 22, 2026 | ±3.4% | +10.8% | under-priced |
| October 29, 2025 | ±2.3% | -4.7% | under-priced |
| July 31, 2025 | ±2.0% | +3.6% | under-priced |
| April 23, 2025 | ±2.7% | -3.4% | under-priced |
| October 29, 2024 | ±2.1% | -0.5% | over-priced |
| July 25, 2024 | ±2.6% | +7.5% | under-priced |
| April 24, 2024 | ±2.0% | -4.5% | under-priced |
| October 26, 2023 | ±2.4% | +6.6% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.05 | $1.9B | $228M |
| Q3 FY2025 | $0.90 | $1.9B | $200M |
| Q2 FY2025 | $1.28 | $2.1B | $283M |
| Q1 FY2025 | $0.87 | $1.8B | $198M |
Masco Corporation (MAS) reports in 83 days, with the next report estimated for September 4, 2026. Across the last 8 reports, options priced an average ±2.5% earnings move while the stock actually moved 5.2% on average — the market has tended to under-price MAS's earnings risk. Fundamentals into the print: EPS up 23.5% year-over-year, revenue up 4.9%. QuantLogix's live 5-factor engine currently reads MAS as a buy at 60/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →